This study is testing a new drug called REGN7544, meant for adults aged 18 to 85 with **sepsis-induced hypotension**. Hypotension is a big word for low blood pressure. Sepsis is a serious condition caused by an infection. The study drug is being tested on patients who are already receiving standard medicines to help with their low blood pressure, known as vasopressors. The main goal of this study is to check how safe and effective this new drug is in raising blood pressure and reducing the need for vasopressors.

Participants will help researchers answer questions like how the drug affects blood pressure, what side effects might occur, and how the body processes the drug. Also, they will check if the body makes antibodies against the drug, which could affect its effectiveness. Participation involves being closely monitored while in the hospital.

• Study length depends on your hospital stay.
• No extra visits are needed beyond hospital stay.
• Potential risks include side effects from the study drug.